CAV

(redirected from Cardiac Allograft Vasculopathy)
AcronymDefinition
CAVComputer-Aided Verification
CAVCavalry
CAVConstant Angular Velocity
CAVCavity
CAVCaveolin
CAVComputer Aided Verification
CAVConcept Activity Vehicle
CAVComposite Audio Video
CAVConstant Air Volume
CAVCampus Andaluz Virtual (Spanish virtual campus)
CAVCanine Adenovirus
CAVCentre d'Art Visuel (French: Visual Art Center; France and Switzerland)
CAVContrat d'Avenir (French: Future Contract; employment contract)
CAVCommon Aero Vehicle
CAVCardiac Allograft Vasculopathy
CAVChicken Anemia Virus
CAVComputer Audio Video (music system)
CAVCollision Avoidance System
CAVCyclophosphamide Doxorubicin Vincristine
CAVCoalition Anti-Vivisection (Belgium)
CAVCommercial Asset Visibility
CAVCentre Alexis Vautrin (French: Alexis Vautrin Center; est. 1924; Vandoeuvre-les-Nancy, France)
CAVComposite Armored Vehicle
CAVCumulative Absolute Velocity (seismology)
CAVConfrérie des Amateurs de Vapeur (French: Brotherhood of Steam Enthusiasts)
CAVComponent Averaging (numerical technique for solving large sparse linear systems)
CAVCommon Aerospace Vehicle
CAVColegio de Arquitectos de Venezuela (Spanish: Venezuela Association of Architects)
CAVCentro Ecuménico Antonio Valdivieso (Antonio Valdivieso Ecumenical Centre)
CAVCommand Assistance Visit (US DoD)
CAVComputer Assisted Valuation (real property)
CAVCentral Africa Vision
CAVCompound Accreted Value
CAVCampo de Visão (Portugese)
CAVChick Anemia Virus
CAVCorrective Action Verification
CAVCentre Astronomique Vendéen (French: Vendéen Astronomical Center; Vendée, France)
CAVClub d'Aviron Vésenaz (French: Rowing Club Vésenaz; Vésenaz, Switzerland)
CAVCommand Assault Vehicle
CAVCrack Arrest Verification
CAVCombat Autonomous Vehicle
CAVClub Automodélisme de Viglain (French: Auto-Modeler Club of Viglain; Viglain, France)
CAVCommand Authority Violation
CAVConsolidated Adjustment Voucher
CAVContrat Assurance Vie (French: Life Insurance Contract)
CAVChampagne Audiovisuel (French: Champagne Audiovisual; Cormontreuil, France)
CAVComputer Aided Vexillology
References in periodicals archive ?
In conclusion, the data of this study indicate that the feature most characteristically associated to cardiac allograft vasculopathy, namely vessel stenosis, was strongly ameliorated by the LDE-MTX treatment, along with the grade of necrosis and markers of the inflammatory process.
Detection and imaging of cardiac allograft vasculopathy.
Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.
HTx patients develop cardiac allograft vasculopathy (CAV) at high rates [1].
Weisz, "Detection and imaging of cardiac allograft vasculopathy," JACC: Cardiovascular Imaging, vol.
Repeated episodes of thrombosis as a potential mechanism of plaque progression in cardiac allograft vasculopathy," European Heart Journal, vol.
Task force 3 covered the myriad of clinical issues occurring long-term after heart transplantation, including cardiac allograft vasculopathy, the chronic adverse effects of immunosuppression (neurotoxicity, renal insufficiency, hypertension, bone disease, diabetes and malignancy), as well as reproductive health, exercise, psychological problems, return to work, and operation of motor vehicles after heart transplantation.
ISHLT recommends the following to properly manage cardiac allograft vasculopathy in Class I transplant patients:
Prevention for cardiac allograft vasculopathy including monitoring of cardiovascular risk factors including hypertension, diabetes, hyperlipidemia, smoking and obesity.
The cumulative effect of acute rejection on development of cardiac allograft vasculopathy.
Cardiac allograft vasculopathy (CAV) is common after successful heart transplantation; the prevalence of angiographically detectable CAV at one, three and five years after transplantation in cyclosporine treated patients is 14%, 37% and 50% respectively (1).
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.